FingerMotion, Inc. 8-K

What Happened
FingerMotion, Inc. (ticker: FNGR) announced in an 8-K that it received a Deficiency Letter from the Nasdaq Listing Qualifications Staff notifying the company that its common stock has closed below the $1.00 minimum bid-price requirement for 30 consecutive business days. Nasdaq has provided a 180-calendar-day compliance period, giving FingerMotion until December 28, 2026 to regain compliance. The Deficiency Letter does not affect current trading — FNGR continues to trade on The Nasdaq Capital Market.

The filing explains the ways to regain compliance: if the closing bid price reaches $1.00 or more for at least ten consecutive business days, Nasdaq will confirm compliance (unless Nasdaq exercises discretion to extend that period). The company may also choose to implement a reverse stock split (if used, it must be completed no later than ten business days before the compliance deadline). If FingerMotion fails to regain compliance, Nasdaq may provide a second 180-day period only if the company meets certain market value and other initial listing standards; failure to comply could lead to a delisting notice and an appeal to a Hearings Panel.

Key Details

• Nasdaq notified FingerMotion of a minimum bid-price deficiency after 30 consecutive business days below $1.00 per share.
• The initial compliance period is 180 calendar days, expiring on December 28, 2026.
• To regain compliance, FNGR must close at $1.00+ for at least 10 consecutive business days (subject to Nasdaq discretion).
• A reverse stock split is an available option but must be completed no later than 10 business days before the compliance date; a possible second 180-day cure period is available only if other listing standards are met.

Why It Matters
This is a material operational listing risk: if FingerMotion does not cure the bid-price deficiency by the deadline (or through a permitted second period), Nasdaq could move to delist FNGR, which can reduce liquidity and make the stock harder to trade. The company says it will monitor the share price and consider options to regain compliance, but there is no assurance it will succeed. Investors should note the compliance timeline and monitor future filings or company announcements about actions (such as a reverse split) or changes in trading price.